Comparative study of therapeutic antibody candidates derived from mini-pool and clonal cell lines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative study of therapeutic antibody candidates derived from mini-pool and clonal cell lines

Published:2017-05-02 Issue:6 Volume:33 Page:1456-1462
ISSN:8756-7938
Container-title:Biotechnology Progress
language:en
Short-container-title:Biotechnol Progress

Author:

Fan Lianchun¹^ORCID,Rizzi Giovanni¹,Bierilo Kathleen¹,Tian Jun²,Yee Joon Chong²,Russell Reb³,Das Tapan K⁴

Affiliation:

1. Cellular Molecular Biology; Bristol-Myers Squibb Company; Pennington NJ 08534

2. Process Development; Bristol-Myers Squibb Company; Devens MA 01434

3. Analytical and Process Development; Bristol-Myers Squibb Company; Pennington NJ 08534

4. Biologics Characterization & Analytical Development; Bristol-Myers Squibb Company; Pennington NJ 08534

Publisher

Wiley

Subject

Biotechnology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/btpr.2477/fullpdf

Reference32 articles.

1. Mammalian cell protein expression for biopharmaceutical production;Zhu;Biotechnol Adv,2012

2. 2016 FDA drug approvals;Mullard;Nat Rev Drug Discov,2017

3. Innovation in the pharmaceutical industry: New estimates of R&D costs;DiMasi;J Health Econ,2016

4. Trends in clinical success rates;Smietana;Nat Rev Drug Discov,2016

5. Competitive Development in Pharmacologic Classes: Market Entry and the Timing of Development;DiMasi;Clin Pharmacol Ther,2016

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The new frontier in CHO cell line development: From random to targeted transgene integration technologies;Biotechnology Advances;2024-10

2. SiMPl‐GS: Advancing Cell Line Development via Synthetic Selection Marker for Next‐Generation Biopharmaceutical Production;Advanced Science;2024-08-06

3. Rapid and Scalable Production of Functional SARS-CoV-2 Virus-like Particles (VLPs) by a Stable HEK293 Cell Pool;Vaccines;2024-05-21

4. Further accelerating biologics development from DNA to IND: the journey from COVID-19 to non-COVID-19 programs;Antibody Therapeutics;2024-01

5. Recombinant CHO Cell Pool Generation Using PiggyBac Transposon System;Methods in Molecular Biology;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3